Serum levels of angioregulatory mediators in healthy individuals depend on age and physical activity:: Studies of angiogenin, basic fibroblast growth factor, leptin and endostatin

被引:21
作者
Bruserud, O [1 ]
Grovan, F
Lindås, R
Moinichen, CB
Osterhus, KK
机构
[1] Haukeland Univ Hosp, Dept Med, Div Haematol, NO-5021 Bergen, Norway
[2] Univ Bergen, Bergen, Norway
关键词
angiogenesis; cytokines;
D O I
10.1080/00365510500209306
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective. Angiogenesis is regulated by a wide range of soluble mediators that are released locally or by distant organs that affect local angiogenesis through variations in systemic levels. Serum levels of angioregulatory mediators are important for muscle angiogenesis in response to physical activity; in addition, angioregulation is involved in disease development, and determination of systemic levels may therefore be useful in future clinical practice. The aim of the present study was to investigate whether physical activity alters systemic levels of angioregulatory mediators in healthy individuals. Material and methods. The effects of physical activity on serum levels of pro- ( angiogenin, basic fibroblast growth factor ( bFGF), leptin) and antiangiogenic ( endostatin) mediators were investigated. The levels were determined immediately before and after activity for healthy young athletes ( all males, age 18 years) and elderly individuals ( 9 M, 11 F, age 68 - 88 years). Results. Elderly individuals showed higher pre-activity levels than the athletes for all mediators. The young athletes showed increased angiogenin and endostatin levels and decreased bFGF levels after 45 min of intensive physical activity, whereas leptin levels were not altered. Elderly individuals showed a similar decrease in bFGF levels after a 3-h mountain walk, but angiogenin, endostatin and leptin levels were not altered. Conclusions. Serum levels of angioregulatory mediators depend on age, and standardization of physical activity prior to sampling will probably be necessary when evaluating the possible clinical use of these parameters.
引用
收藏
页码:505 / 511
页数:7
相关论文
共 14 条
[1]  
Eliakim A, 2000, AM J PHYSIOL-REG I, V279, pR548
[2]  
Gabrilove JL, 2001, ONCOLOGIST, V6, P4
[3]   Serum levels of angiogenin, basic fibroblast growth factor and endostatin in patients receiving intensive chemotherapy for acute myelogenous leukemia [J].
Glenjen, N ;
Mosevoll, KA ;
Bruserud, O .
INTERNATIONAL JOURNAL OF CANCER, 2002, 101 (01) :86-94
[4]   Antiangiogenic therapy in acute myelogenous leukemia: Targeting of vascular endothelial growth factor and interleukin 8 as possible antileukemic strategies [J].
Hatfield, KJ ;
Olsnes, AM ;
Gjertsen, BT ;
Bruserud, O .
CURRENT CANCER DRUG TARGETS, 2005, 5 (04) :229-248
[5]   Lack of antitumor activity of recombinant endostatin in a human neuroblastoma xenograft model [J].
Jouanneau, E ;
Alberti, L ;
Nejjari, M ;
Treilleux, I ;
Vilgrain, I ;
Duc, A ;
Combaret, V ;
Favrot, M ;
Leboulch, P ;
Bachelot, T .
JOURNAL OF NEURO-ONCOLOGY, 2001, 51 (01) :11-18
[6]  
Kisker O, 2001, CANCER RES, V61, P7298
[7]   Prolonged exercise decreases serum leptin concentrations [J].
Landt, M ;
Lawson, GM ;
Helgeson, JM ;
DavilaRoman, VG ;
Ladenson, JH ;
Jaffe, AS ;
Hickner, RC .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1997, 46 (10) :1109-1112
[8]   Serum leptin levels in male marathon athletes before and after the marathon run [J].
Leal-Cerro, A ;
Garcia-Luna, PP ;
Astorga, R ;
Parejo, J ;
Peino, R ;
Dieguez, C ;
Casanueva, FF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (07) :2376-2379
[9]   Setbacks for endostatin [J].
Marshall, E .
SCIENCE, 2002, 295 (5563) :2198-2199
[10]   Differential effects of maximal- and moderate-intensity runs on plasma leptin in healthy trained subjects [J].
Olive, JL ;
Miller, GD .
NUTRITION, 2001, 17 (05) :365-369